Literature DB >> 30559237

11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2018 by the American Diabetes Association.

Entities:  

Year:  2019        PMID: 30559237     DOI: 10.2337/dc19-S011

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  125 in total

Review 1.  Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

Authors:  Brendon L Neuen; David Z Cherney; Meg J Jardine; Vlado Perkovic
Journal:  CMAJ       Date:  2019-10-15       Impact factor: 8.262

2.  Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study.

Authors:  Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873

3.  Associations Between Racial and Ethnic Groups and Foot Self-Inspection in People With Diabetes.

Authors:  Alyson J Littman; Catherine J Knott; Edward J Boyko; Stephen E Hawes
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

4.  Continuous Glucose Monitoring in General Wards for Prevention of Hypoglycemia: Results From the Glucose Telemetry System Pilot Study.

Authors:  Lakshmi G Singh; David L Levitt; Medha Satyarengga; Lillian Pinault; Min Zhan; John D Sorkin; Jeffrey C Fink; Guillermo E Umpierrez; Elias K Spanakis
Journal:  J Diabetes Sci Technol       Date:  2019-11-28

5.  Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.

Authors:  Risa M Wolf; Roomasa Channa; Michael D Abramoff; Harold P Lehmann
Journal:  JAMA Ophthalmol       Date:  2020-10-01       Impact factor: 7.389

6.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

7.  5-Hydroxymethylcytosines in Circulating Cell-Free DNA Reveal Vascular Complications of Type 2 Diabetes.

Authors:  Ying Yang; Chang Zeng; Xingyu Lu; Yanqun Song; Ji Nie; Ruoxi Ran; Zhou Zhang; Chuan He; Wei Zhang; Song-Mei Liu
Journal:  Clin Chem       Date:  2019-10-01       Impact factor: 8.327

8.  The SONAR study-is there a future for endothelin receptor antagonists in diabetic kidney disease?

Authors:  Avivit Cahn; Simona Cernea; Itamar Raz
Journal:  Ann Transl Med       Date:  2019-12

9.  How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?

Authors:  Joshua J Neumiller; Rita R Kalyani
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-01       Impact factor: 8.237

10.  Effects of dietary protein intake on renal outcome and mortality in patients with advanced diabetic nephropathy.

Authors:  Eriko Tauchi; Ko Hanai; Tetsuya Babazono
Journal:  Clin Exp Nephrol       Date:  2019-10-05       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.